Coronary heart disease (CHD) is one of the most common heart diseases worldwide and is currently grouped into two syndromes: acute coronary syndrome (ACS) and chronic coronary syndrome (CCS). Following revascularization, patients with ACS and CCS are usually treated in the medium and long term by both general practitioners and cardiologists. The current guidelines of the European Society of Cardiology (ESC) emphasize that the assessment of the individual ischemia and bleeding risk is an important basis for the choice of an adequate antithrombotic strategy.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Vaccine-preventable respiratory diseases
RSV and pneumococci: recommendations for risk groups
- Circadian rhythm in asthma
Chronotherapy can improve control
- Update on diagnostics, risk stratification and therapy
Acute myeloid leukemia 2025
- New practice guideline for fibromyalgia syndrome
Good times, bad times
- Findings from the TRACK-FA study
Neuroimaging biomarkers in Friedreich’s ataxia
- Doing sport without fear or risk
Doing sport without fear or risk
- Chronic inducible urticaria
What has stayed the same, what has changed?
- National Health Report 2025